VEGFA and triple-negative breast carcinoma: In addition, VEGF was found to be correlated with the treatment response to neoadjuvant chemotherapy and is regarded as a reliable predictive biomarker for a pathological complete response and disease relapse in triple-negative breast cancer [22].